The evidence that HLA-G may inhibit tumor cell proliferation was consolidated by studies using bone marrow (BM) samples from multiple myeloma patients where HLA-G limits CD138− stem cell differentiation into CD138+ multiple myeloma cells [34]. This evidence concerns the gene SDC1 and plasma cell myeloma.